Skip to content
ApprovedFDA approvedStrong evidence

Clomipramine

Prescription tricyclic antidepressant (Anafranil) used for obsessive-compulsive disorder, depression and panic disorder.

AntidepressantTricyclic antidepressantAntidepressantMoodSerotoninNorepinephrine

Pharmacology

ClassAntidepressant · Mood
Primary targetSerotonin transporter (SERT) reuptake inhibition
Targets5 receptor targets
Half-lifeClomipramine ~32 hours; its active metabolite (desmethylclomipramine) is longer, ~54-77 hours
OnsetAnxiolytic/antidepressant effect develops over 2-6 weeks
EvidenceStrong evidence
Affected systemsSerotoninNorepinephrine

Contents

DETAILED OVERVIEW

What is Clomipramine?

Clomipramine (Anafranil) is a prescription antidepressant from the tricyclic group. In the United States it is approved for obsessive-compulsive disorder (OCD); in Europe it is also approved for depression and further conditions. It has been found effective in depression and panic disorder too, and in premature ejaculation it lengthens the time until ejaculation.

It blocks the reuptake of serotonin and, to a lesser degree, noradrenaline, so these two messengers stay longer between nerve cells; of all tricyclic drugs it acts most strongly on the serotonin system. Side effects can include dry mouth, drowsiness, dizziness on standing up and problems with sexual function. It can lower the seizure threshold, so the risk of seizures is higher in epilepsy. It must not be taken with MAO inhibitors (risk of serotonin syndrome), and children and young people face a higher risk of suicidal thoughts. An overdose is toxic to the heart and life-threatening.

Mechanism

Serotonin and norepinephrine reuptake inhibition (TCA)

Main indication

OCD (FDA-approved), depression, panic

Legal status

Prescription-only medicine

Receptor profile

  • Serotonin transporter (SERT)Strong
  • Norepinephrine transporter (via active metabolite)Strong
  • Histamine H1 receptorModerate
  • Muscarinic acetylcholine receptorsModerate
  • Alpha-1 adrenergic receptorModerate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Anticholinergic effects: dry mouth, constipation, blurred vision, urinary retention
  • Sedation, drowsiness and weight gain from H1 blockade
  • Orthostatic hypotension and dizziness from alpha-1 blockade
  • Sexual dysfunction: delayed or inhibited orgasm, reduced libido
  • Sweating, tremor, dose-dependent seizure risk (lowering of the seizure threshold)
  • Cardiotoxicity in overdose: QT prolongation, arrhythmia; TCA overdose is life-threatening

Contraindications · 5

  • With an MAO inhibitor or within 14 days of stopping one: risk of serotonin syndrome
  • Recent myocardial infarction, severe conduction disorder or known QT prolongation
  • Narrow-angle glaucoma, clinically significant prostate enlargement (urinary retention)
  • Epilepsy or lowered seizure threshold: increased seizure risk
  • Manic phase; increased suicidal ideation risk in children and young adults, close monitoring required

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Clomipramine (Anafranil) is a long-established, prescription-only antidepressant used mainly to treat obsessive-compulsive disorder (OCD), where it's one of the best-proven medications available. It's also used for depression and panic disorder, and it's sometimes prescribed for premature ejaculation because it delays ejaculation.

Telegram

Have a question about Clomipramine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC19H23ClN2
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.